Epithelial ovarian cancer with CD117 phenotype is highly aggressive and resistant to chemotherapy
- 14 July 2015
- journal article
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 41 (10) , 1630-1637
Abstract
Aim: CD117 expression has a pathogenic role in many malignancies, including ovarian carcinoma. The aim of the present study was to examine the correlation of stemness‐associated marker CD117 with the clinicopathologic features of epithelial ovarian cancer and patient survival.Material and Methods: The analysis included 240 primary ovarian carcinomas (OC) diagnosed during the period from 2005 to 2011 in the region of South Serbia. Age, pathohistological characteristics, presence and size of residual tumor, choice of therapy and response to the therapy were studied.Results: Residual tumors were more frequently present in the patients with positive CD117 expression (18.1% vs 8.0%; P < 0.05). Chemotherapy according to paclitaxel/carboplatin protocol was more frequent in the patients with positive CD117 expression (70.9% vs 54.2%; P < 0.05), while carboplatin monotherapy was more frequent in the patients with negative CD117 expression (18.0% vs 6.4%; P < 0.05). Median survival time in patients with CD117‐positive mucinous and endometrioid OC was significantly shorter, at 20 and 26.8 months, respectively. Median survival in serous OC was not related to CD117 expression.Conclusion: Residual tumors and chemotherapy treatment were more frequent in patients with positive CD117 expression. The outcome was dependent on the type of OC; a worse outcome, including a shorter survival, was documented in the mucinous and endometrioid OC cases.Keywords
Funding Information
- Ministry of education, science and technological development of Serbia (175092)
This publication has 18 references indexed in Scilit:
- The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agentsBlood, 2013
- The prognostic impact of c-KIT mutation in systemic mastocytosis associated with acute myeloid leukaemia patientsLeukemia Research, 2013
- Cyclic AMP and c-KIT Signaling in Familial Testicular Germ Cell Tumor PredispositionThe Journal of Clinical Endocrinology & Metabolism, 2013
- Phosphorylation of the Activation Loop Tyrosine 823 in c-Kit Is Crucial for Cell Survival and ProliferationJournal of Biological Chemistry, 2013
- CD117 expression in operable oesophageal squamous cell carcinomas predicts worse clinical outcomeHistopathology, 2013
- KIT (CD117) Expression in a Subset of Non-Small Cell Lung Carcinoma (NSCLC) PatientsPLOS ONE, 2012
- Cancer Stem Cells and Aneuploid Populations within Developing Tumors Are the Major Determinants of Tumor DormancyCancer Research, 2009
- The Side Population of Ovarian Cancer Cells Is a Primary Target of IFN-α Antitumor EffectsCancer Research, 2008
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human TumorsCancer Research, 2008
- Correlation of Murine Embryonic Stem Cell Gene Expression Profiles with Functional Measures of PluripotencyStem Cells, 2005